| pubmed-article:19447443 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:19447443 | lifeskim:mentions | umls-concept:C0005684 | lld:lifeskim |
| pubmed-article:19447443 | lifeskim:mentions | umls-concept:C0205462 | lld:lifeskim |
| pubmed-article:19447443 | lifeskim:mentions | umls-concept:C0332305 | lld:lifeskim |
| pubmed-article:19447443 | lifeskim:mentions | umls-concept:C0442805 | lld:lifeskim |
| pubmed-article:19447443 | lifeskim:mentions | umls-concept:C0439064 | lld:lifeskim |
| pubmed-article:19447443 | lifeskim:mentions | umls-concept:C2348519 | lld:lifeskim |
| pubmed-article:19447443 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:19447443 | pubmed:dateCreated | 2009-6-12 | lld:pubmed |
| pubmed-article:19447443 | pubmed:abstractText | The clinical under staging of T1 bladder cancer potentially delays therapy and undermines survival. In this study we evaluated clinicopathological features to aid in the identification of patients with clinical T1 bladder cancer at risk for under staging. | lld:pubmed |
| pubmed-article:19447443 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19447443 | pubmed:language | eng | lld:pubmed |
| pubmed-article:19447443 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19447443 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:19447443 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:19447443 | pubmed:month | Jul | lld:pubmed |
| pubmed-article:19447443 | pubmed:issn | 1527-3792 | lld:pubmed |
| pubmed-article:19447443 | pubmed:author | pubmed-author:WeizerAlon... | lld:pubmed |
| pubmed-article:19447443 | pubmed:author | pubmed-author:ShahRajal BRB | lld:pubmed |
| pubmed-article:19447443 | pubmed:author | pubmed-author:LeeCheryl TCT | lld:pubmed |
| pubmed-article:19447443 | pubmed:author | pubmed-author:WangRouR | lld:pubmed |
| pubmed-article:19447443 | pubmed:author | pubmed-author:DaignaultStep... | lld:pubmed |
| pubmed-article:19447443 | pubmed:author | pubmed-author:WascoMatthew... | lld:pubmed |
| pubmed-article:19447443 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:19447443 | pubmed:volume | 182 | lld:pubmed |
| pubmed-article:19447443 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:19447443 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:19447443 | pubmed:pagination | 59-65; discussion 65 | lld:pubmed |
| pubmed-article:19447443 | pubmed:dateRevised | 2010-11-18 | lld:pubmed |
| pubmed-article:19447443 | pubmed:meshHeading | pubmed-meshheading:19447443... | lld:pubmed |
| pubmed-article:19447443 | pubmed:meshHeading | pubmed-meshheading:19447443... | lld:pubmed |
| pubmed-article:19447443 | pubmed:meshHeading | pubmed-meshheading:19447443... | lld:pubmed |
| pubmed-article:19447443 | pubmed:meshHeading | pubmed-meshheading:19447443... | lld:pubmed |
| pubmed-article:19447443 | pubmed:meshHeading | pubmed-meshheading:19447443... | lld:pubmed |
| pubmed-article:19447443 | pubmed:meshHeading | pubmed-meshheading:19447443... | lld:pubmed |
| pubmed-article:19447443 | pubmed:meshHeading | pubmed-meshheading:19447443... | lld:pubmed |
| pubmed-article:19447443 | pubmed:meshHeading | pubmed-meshheading:19447443... | lld:pubmed |
| pubmed-article:19447443 | pubmed:meshHeading | pubmed-meshheading:19447443... | lld:pubmed |
| pubmed-article:19447443 | pubmed:meshHeading | pubmed-meshheading:19447443... | lld:pubmed |
| pubmed-article:19447443 | pubmed:meshHeading | pubmed-meshheading:19447443... | lld:pubmed |
| pubmed-article:19447443 | pubmed:meshHeading | pubmed-meshheading:19447443... | lld:pubmed |
| pubmed-article:19447443 | pubmed:meshHeading | pubmed-meshheading:19447443... | lld:pubmed |
| pubmed-article:19447443 | pubmed:meshHeading | pubmed-meshheading:19447443... | lld:pubmed |
| pubmed-article:19447443 | pubmed:meshHeading | pubmed-meshheading:19447443... | lld:pubmed |
| pubmed-article:19447443 | pubmed:meshHeading | pubmed-meshheading:19447443... | lld:pubmed |
| pubmed-article:19447443 | pubmed:meshHeading | pubmed-meshheading:19447443... | lld:pubmed |
| pubmed-article:19447443 | pubmed:meshHeading | pubmed-meshheading:19447443... | lld:pubmed |
| pubmed-article:19447443 | pubmed:meshHeading | pubmed-meshheading:19447443... | lld:pubmed |
| pubmed-article:19447443 | pubmed:meshHeading | pubmed-meshheading:19447443... | lld:pubmed |
| pubmed-article:19447443 | pubmed:meshHeading | pubmed-meshheading:19447443... | lld:pubmed |
| pubmed-article:19447443 | pubmed:meshHeading | pubmed-meshheading:19447443... | lld:pubmed |
| pubmed-article:19447443 | pubmed:meshHeading | pubmed-meshheading:19447443... | lld:pubmed |
| pubmed-article:19447443 | pubmed:meshHeading | pubmed-meshheading:19447443... | lld:pubmed |
| pubmed-article:19447443 | pubmed:meshHeading | pubmed-meshheading:19447443... | lld:pubmed |
| pubmed-article:19447443 | pubmed:meshHeading | pubmed-meshheading:19447443... | lld:pubmed |
| pubmed-article:19447443 | pubmed:meshHeading | pubmed-meshheading:19447443... | lld:pubmed |
| pubmed-article:19447443 | pubmed:meshHeading | pubmed-meshheading:19447443... | lld:pubmed |
| pubmed-article:19447443 | pubmed:meshHeading | pubmed-meshheading:19447443... | lld:pubmed |
| pubmed-article:19447443 | pubmed:year | 2009 | lld:pubmed |
| pubmed-article:19447443 | pubmed:articleTitle | Multiple adverse histological features increase the odds of under staging T1 bladder cancer. | lld:pubmed |
| pubmed-article:19447443 | pubmed:affiliation | Department of Urology, University of Michigan, Ann Arbor, Michigan, USA. aweizer@umich.edu | lld:pubmed |
| pubmed-article:19447443 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:19447443 | pubmed:publicationType | Comparative Study | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19447443 | lld:pubmed |
